Johnson Philip L's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Jul 2, 2026
- Accession no.
- 0002013156-26-000007
- Filed
- Jul 2, 2026, 6:04 PM ET
- Trade date
- Jun 30, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnson Philip LCIK 0002013156 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Ordinary Shares | FTax withholdingDisposed | −3,343 | $237.72 | −$794,697.96 | 56,431 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.